| |
| SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis |
| Riemsma R, Al M, Corro Ramos I, Deshpande S, Armstrong N, Lee YC, Ryder S, Noake C, Krol M, Oppe M, Kleijnen J, Severens H |
|
|
| |
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Riemsma R, Al M, Corro Ramos I, Deshpande S, Armstrong N, Lee YC, Ryder S, Noake C, Krol M, Oppe M, Kleijnen J, Severens H. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis. Health Technology Assessment 2013; 17(61): 1-236 Indexing Status Subject indexing assigned by NLM MeSH Adult; Bile Acids and Salts /economics /metabolism /therapeutic use; Chronic Disease; Cost-Benefit Analysis; Crohn Disease /diagnosis /drug therapy /economics /physiopathology; Diagnosis, Differential; Diarrhea /diagnosis /drug therapy /economics /etiology; Great Britain; Humans; Irritable Bowel Syndrome /diagnosis /drug therapy /economics /physiopathology; Malabsorption Syndromes /diagnosis /drug therapy /economics /physiopathology; Models, Economic; Predictive Value of Tests; Taurocholic Acid /analogs & derivatives /economics AccessionNumber 22014008658 Date bibliographic record published 12/03/2014 |
| |
|
|
